Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro

This publication has 28 references indexed in Scilit:

• Growth factors and their receptors in prostate cancer
  BJU International, 2002
• Neuropeptide-Induced Androgen Independence in Prostate Cancer Cells: Roles of Nonreceptor Tyrosine Kinases Etk/Bmx, Src, and Focal Adhesion Kinase
  Molecular and Cellular Biology, 2001
• The development of androgen-independent prostate cancer
  Nature Reviews Cancer, 2001
• Src inhibitors: genomics to therapeutics
  Expert Opinion on Investigational Drugs, 2001
• Active Recombinant Human Tyrosine Kinase c-Yes: Expression in Baculovirus System, Purification, Comparison to c-Src, and Inhibition by a c-Src Inhibitor
  Protein Expression and Purification, 2000
• Substituted 5,7-diphenyl-pyrrolo[2,3 d ]pyrimidines: potent inhibitors of the tyrosine kinase c-Src
  Bioorganic & Medicinal Chemistry Letters, 2000
• Tyrosine kinase Src inhibitors: Potential therapeutic applications
  Drug News & Perspectives, 2000
• A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo
  Bone, 1999
• CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
  Annual Review of Cell and Developmental Biology, 1997
• A tyrosine kinase profile of prostate carcinoma.
  Proceedings of the National Academy of Sciences, 1996